Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Medistim ASA (MEDI) NOK0.25

Sell:259.00 NOK Buy:286.00 NOK Change: 3.00 NOK (1.07%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Sell:259.00 NOK
Buy:286.00 NOK
Change: 3.00 NOK (1.07%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Sell:259.00 NOK
Buy:286.00 NOK
Change: 3.00 NOK (1.07%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The Company provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

Contact details

Okernveien 94
+47 (2) 3059660

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
5.08 billion NOK
Shares in issue:
18.20 million
Health Care Equipment
Oslo Stock Exchange
Norwegian Krone

Key personnel

  • Oyvin Broymer
    Chairman of the Board
  • Kari Krogstad
    President, Chief Executive Officer
  • Bjorn Wiggen
    Deputy Chairman of the Board
  • Thomas Jakobsen
    Chief Financial Officer
  • Mike Farbelow
    President of Medistim USA, Inc.
  • Ole Robsrud
    Managing Director Medistim Norge AS
  • Roger Morberg
    Vice President Sales
  • Haege Krogh Wetterhus
    Vice President Marketing
  • Anders Lillebo
    Vice President Manufacturing
  • Tone Veiteberg
    Vice President Regulatory Affairs & Quality Assurance

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.